Phase IIa trial of CNT-01 for patients with idiopathic triglyceride deposit cardiomyovasculopathy.
- Conditions
- Idiopathic triglyceride deposit cardiomyovasculopathy (TGCV).
- Registration Number
- JPRN-UMIN000035403
- Lead Sponsor
- Osaka university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Not provided
1) Patients within 1 month of revascularization of coronary arteries 2) Patients with fasting serum capric acid concentration> 10 umol / L 3) Patients who had diet therapy containing medium chain fatty acid even once in the past 4) Patients with diabetic ketoacidosis 5) A pregnant patient, a pregnant woman or a lactating patient 6) Class IV patients with NYHA cardiac function classification 7) Patients with acute coronary syndrome 8) Patients with a history of drug addiction 9) Patients who are allergic to the ingredients of the CNT-01 10) Patients who are allergic to BMIPP or iodine 11) Patients with a history of clinically important drug allergic symptoms 12) Patients with severe liver dysfunction (Child-Pugh classifications B or C) 13) Patients who took part in other clinical trial studies within 3 months 14) Patients judged unsuitable for inclusion in this clinical trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method